Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

New therapies, new technologies, global supply chain challenges, and political pressures draw pharma professionals to major industry event.

Market Dynamics Drive the Agenda for CPhI Worldwide

GSK’s expanded R&D and manufacturing facility in Upper Merion, PA houses a new analytical lab and flexible manufacturing equipment, including single-use bioreactors.

GSK Invests $120 million in US Biopharmaceutical Manufacturing Facility

FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.

FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of AstraZeneca’s Qtrilmet (metformin hydrochloride, saxagliptin, and dapagliflozin) modified-release tablets for treating type-2 diabetes.

AstraZeneca’s Combination Diabetes Pill Recommended for Approval in EU

Procarta Biosystems has received an award from CARB-X, potentially worth $9.2 million, for the development of antibiotic precision medicines.


UK Biotech Receives CARB-X Award Worth $9.2 Million

PSE, a supplier of advanced process modeling software and services, plans to become part of Siemens Digital Industries. 

Siemens Plans to Acquire PSE

Nephron Pharma and the University of South Carolina plan to build a sterile compounding lab at the University for research and training. 

Nephron, UofSC Researchers Collaborate on Automation

Agnes Shanley is senior editor of Pharmaceutical Technology.

A GAO report analyzes some of the reasons why so few generics are approved the first time around. NIPTE has proposed a program that would address these issues. 

Generics: Getting Beyond “File First, Figure it Out Later”

The new facility will handle clinical supply management, primary and secondary packaging, complex labeling services, clinical storage, distribution, and drug returns and destruction and will include stability chambers.

Catalent to Invest $9 Million to Establish San Diego Clinical Supply Facility

Valo Therapeutics has acquired a technology from Helsinki University that is expected to broaden its approach and expand the capability of its cancer vaccines platform, PeptiCRAd.
